Mario Gabelli Eli Lilly & CO Transaction History

Gamco Investors, Inc. Et Al

$9 Billion
Q3 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Eli Lilly & CO stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 34,812 shares of LLY stock, worth $26 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

34,812

Previous 35,829 2.84%

Holding current value

$26 Million

Previous $32.4 Million 4.92%

% of portfolio

0.34%

Previous 0.38%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $785,266 - $976,340	-1,017 Reduced 2.84%	34,812 $30.8 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $376,932 - $472,700	-520 Reduced 1.43%	35,829 $32.4 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $3.42 Million - $4.57 Million	5,768 Added 18.86%	36,349 $28.3 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $388,187 - $535,174	-893 Reduced 2.84%	30,581 $16.4 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $330,046 - $441,310	941 Added 3.08%	31,474 $14.8 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $100,022 - $117,472	-322 Reduced 1.04%	30,533 $10.5 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $3.78 Million - $4.41 Million	11,759 Added 61.58%	30,855 $11.3 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $215,244 - $245,293	726 Added 3.95%	19,096 $6.18 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $151,907 - $178,362	-545 Reduced 2.88%	18,370 $5.96 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $52,805 - $65,623	-225 Reduced 1.18%	18,915 $5.42 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $28,106 - $34,880	-125 Reduced 0.65%	19,140 $5.29 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $158,222 - $194,714	-714 Reduced 3.57%	19,265 $4.45 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $219,548 - $283,984	-1,216 Reduced 5.74%	19,979 $4.59 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $13,638 - $17,655	83 Added 0.39%	21,195 $3.96 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $181,600 - $240,300	-1,392 Reduced 6.19%	21,112 $3.57 Million
Q3 2020 Nov 06, 2020	BUY	$146.22 - $169.13 $28,074 - $32,472	192 Added 0.86%	22,504 $3.33 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $736,667 - $886,572	-5,400 Reduced 19.49%	22,312 $3.66 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $226,195 - $279,965	-1,900 Reduced 6.42%	27,712 $3.84 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $387,585 - $480,058	-3,625 Reduced 10.91%	29,612 $3.89 Million
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $128,148 - $139,392	-1,200 Reduced 3.48%	33,237 $3.72 Million
Q2 2019 Aug 02, 2019	BUY	$110.79 - $129.32 $1.03 Million - $1.2 Million	9,300 Added 37.0%	34,437 $3.82 Million
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $1.24 Million - $1.45 Million	-11,103 Reduced 30.64%	25,137 $3.26 Million
Q4 2018 Jan 30, 2019	SELL	$105.9 - $118.64 $479,197 - $536,846	-4,525 Reduced 11.1%	36,240 $4.19 Million
Q3 2018 Nov 02, 2018	SELL	$85.86 - $107.31 $734,103 - $917,500	-8,550 Reduced 17.34%	40,765 $4.37 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $123,769 - $142,048	-1,635 Reduced 3.21%	49,315 $4.21 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $85,341 - $100,740	-1,150 Reduced 2.21%	50,950 $3.94 Million
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $1.78 Million - $1.91 Million	-21,750 Reduced 29.45%	52,100 $4.4 Million
Q3 2017 Nov 01, 2017	BUY	$77.07 - $85.54 $5.69 Million - $6.32 Million	73,850	73,850 $6.32 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account